Internal Medicine, Gastroenterology · Orange, CA
NPI
1821101163
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1140 W la Veta Ave, Ste 555
Orange, CA, 92868
Phone (714) 835-5100
Groups this clinician bills Medicare through
Medicare paid, 2024
$76K
710 services
Medicare patients, 2024
334
Average age 74
Drug cost, 2024
$38K
185 prescriptions
Company payments, 2025
$440
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David B Stanton was code 99213 (office e&m - established), 330 times for 176 patients. In total David B Stanton billed 710 services in 18 codes, and Medicare paid $76K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-01-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 330 | 176 | $75.26 | $25K |
| 43239 Upper GI Endoscopy | Facility | 110 | 109 | $83.11 | $9,143 |
| 45385 Colonoscopy - Lesion Removal | Facility | 80 | 80 | $200.07 | $16K |
| 99203 Office E&M - New | Office | 69 | 69 | $87.79 | $6,058 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 32 | 32 | $204.45 | $6,543 |
| 45380 Lower GI Endoscopy - Other | Facility | 28 | 28 | $122.58 | $3,432 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 27 | 27 | $204.22 | $5,514 |
| 45378 Lower GI Endoscopy - Other | Facility | 12 | 12 | $149.41 | $1,793 |
By year: 2022 $75K for 797 services; 2023 $74K for 733 services; 2024 $76K for 710 services.
Medicare prescription drug claims, 2024
In 2024, the drug David B Stanton prescribed most often to Medicare patients was Diphenoxylate-Atropine (Diphenoxylate Hcl/Atropine), with 16 prescriptions and refills. In total David B Stanton wrote 185 Medicare prescriptions that cost $38K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 16 | 16 | Under 11 | $466 |
| Omeprazole Generic | 14 | 40 | Under 11 | $213 |
| Sucralfate Generic | 13 | 18 | Under 11 | $480 |
| Insulin Syringe Syringe And Needle,insulin,1ml | 13 | 13 | Under 11 | $1,028 |
| Loperamide Loperamide Hcl | 12 | 12 | Under 11 | $351 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 12 | 12 | Under 11 | $70.62 |
| Amitriptyline Hcl Generic | 11 | 17 | Under 11 | $197 |
| Nalbuphine Hcl Generic | 11 | 11 | Under 11 | $10K |
Brand drugs: 40 claims; generic drugs: 132 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David B Stanton $440 ($440 in general payments such as food, travel and fees) from 9 companies. The largest payer was Janssen Biotech, Inc. with $96.44.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 4 | $96.44 |
| Madrigal Pharmaceuticals MDGL | 3 | $95.32 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $51.35 |
| Ardelyx, Inc. ARDX | 3 | $50.56 |
| Genzyme Corporation SNY | 2 | $42.66 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $37.27 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $30.86 |
| Pfizer Inc. PFE | 1 | $21.07 |
| Aimmune Therapeutics, Inc. | 1 | $14.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.